Literature DB >> 2963792

Skin reactions to co-trimoxazole.

E Schöpf1.   

Abstract

Like many other drugs co-trimoxazole can induce a large number of different skin reactions, mainly of allergic pathogenesis. The majority of these reactions, such as urticarial, purpuric, maculo-papular, and pustular exanthemas as well as photallergic reactions, generally do not endanger the life of the patient. Apart from very rare cases of anaphylactic shock, there is a risk of lethality associated with Stevens-Johnson syndrome and Lyell's syndrome of approximately 1% and 30%, respectively. Between 1981 and 1985, an extensive epidemiological survey was carried out in Germany which enabled approximation of drug induced severe skin reactions (Lyell's syndrome, Stevens-Johnson syndrome). Preliminary evaluation of the survey allowed the identification of 217 Lyell's syndromes and 296 Stevens-Johnson syndromes. The total registration rate resulting from an almost complete survey of all applicable medical units (dermatology, burns, intensive care) was 92%. The basic risk amongst the population of acquiring Lyell's syndrome and Stevens-Johnson syndrome, as calculated from the data gathered between 1981 and 1985, is 0.8 and 1.0 per year, and per one million inhabitants respectively, in the drug-related incidence calculation. Co-trimoxazole is in the upper third of the table of drugs which certainly, probably, or possibly induced a Lyell's syndrome and in the middle of the table of those that induced Stevens-Johnson syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963792     DOI: 10.1007/bf01643199

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  [Toxic epidermal necrolysis (Lyell syndrome)].

Authors:  U N Dürst; E Müller; T Pfister; W Künzi; G Zellweger; M V Spiegel
Journal:  Schweiz Med Wochenschr       Date:  1986-05-24

2.  [Toxic epidermal necrolysis (Lyell's syndrome) (author's transl)].

Authors:  N Hunziker
Journal:  Schweiz Rundsch Med Prax       Date:  1979-02-27

Review 3.  [Allergological studies of the Lyell syndrome].

Authors:  E Schöpf; K H Schulz; R Kessler; M Taugner; W Braun
Journal:  Z Hautkr       Date:  1975-10-15

4.  An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs.

Authors:  R S Stern; M Bigby
Journal:  JAMA       Date:  1984-09-21       Impact factor: 56.272

5.  The mucocutaneous syndromes--Erythema multiforme, Stevens-Johnson and Ectodermosis erosiva pluriorificialis.

Authors:  R P Brettle; J A Gray; G Sangster; J M Murdoch; H M Dick
Journal:  J Infect       Date:  1982-03       Impact factor: 6.072

6.  Stevens-Johnson syndrome due to co-trimoxazole.

Authors:  S Kikuchi; T Okazaki
Journal:  Lancet       Date:  1978-09-09       Impact factor: 79.321

7.  [Lyell's disease (author's transl)].

Authors:  A Kint; M L Geerts; J de Weert
Journal:  Dermatologica       Date:  1981

8.  Sulindac-induced Stevens-Johnson syndrome: report of 3 cases.

Authors:  Z Husain; L A Runge; J M Jabbs; J A Hyla
Journal:  J Rheumatol       Date:  1981 Jan-Feb       Impact factor: 4.666

9.  Toxic epidermal necrolysis in Stevens--Johnson syndrome.

Authors:  D Assaad; L From; D Ricciatti; H Shapero
Journal:  Can Med Assoc J       Date:  1978-01-21       Impact factor: 8.262

10.  Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982.

Authors:  M Bigby; S Jick; H Jick; K Arndt
Journal:  JAMA       Date:  1986-12-26       Impact factor: 56.272

View more
  4 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Cotrimoxazole Induced Steven Johnson Syndrome: A Case Report.

Authors:  Ayushma Acharya; Shreedhar Prasad Acharya; Tulsi Ram Bhattarai
Journal:  JNMA J Nepal Med Assoc       Date:  2020-09-27       Impact factor: 0.406

Review 3.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

4.  Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.

Authors:  Zacchaeus Anywaine; Jonathan Levin; Ronnie Kasirye; Joseph Kayiira Lutaakome; Andrew Abaasa; Andrew Nunn; Heiner Grosskurth; Paula Munderi
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.